Nn9535-4820
Research payments
$2,826,999
Through program year 2024, $2,826,999 in research payments was reported against Nn9535-4820, across 10,362 payments.
- Paid by (largest first)
- Novo Nordisk AS; Novo Nordisk Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $405,917 | 87 |
| 2023 | Research | $1,484,928 | 2,125 |
| 2022 | Research | $936,154 | 8,150 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Rodolfo Perez Hialeah, FL Named on 715 payments
- Joanna Van Colton, CA Named on 662 payments
- Lazaro Nunez Coral Gables, FL Named on 551 payments
- Gary Yeoman Philadelphia, PA Named on 482 payments
- Neil Fraser Troy, MI Named on 452 payments
- Alexander Murray Greensboro, NC Named on 410 payments
- Gary Soucie Blackfoot, ID Named on 372 payments
- Alefia Tapia Paris, TX Named on 356 payments
- Miguel Trevino Clearwater, FL Named on 351 payments
- Neil Farris Lexington, KY Named on 327 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.